BioCentury
ARTICLE | Financial News

Five Prime amends IPO

September 9, 2013 7:00 AM UTC

Five Prime Therapeutics Inc., South San Francisco, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 7/26/13 Type: IPO To be raised: Up to $60 million Shares: 4 million Price: $12-$14 ...